Business · 13/12/1996

FDA Requests Environmental Data for Paclitaxel Drug Products in New Drug Applications

The US Food and Drug Administration (FDA) is requiring pharmaceutical companies to include environmental information in their New Drug Applications (NDAs), Abbreviated New Drug Applications (ANDAs), and Investigational New Drug Applications (INDs) for paclitaxel drug products, a chemotherapy medication used to treat various types of cancer.